A novel organometallic aqua complex of technetium for the labeling of biomolecules:: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in aqueous solution and its reaction with a bifunctional ligand
A novel organometallic aqua complex of technetium for the labeling of biomolecules:: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in aqueous solution and its reaction with a bifunctional ligand
复制标题
DOI:
10.1021/ja980745t
复制
发表时间:
1998-08-12
影响因子:
15
通讯作者:
Kaden, TA
中科院分区:
文献类型:
--
作者:
Alberto, R;Schibli, R;Kaden, TA
We present herein the first synthesis of the water and air stable organometallic aqua complex [99mTc (OH2) 3 (CO) 3]+ directly from [99mTcO4]-in saline under 1 atm of CO. Subsequent substitution of the labile water ligands by a bifunctional ligand attachable to biomolecules enables the introduction of carbonyl complexes in life sciences in general and in nuclear medicine in particular. The application of organometallic complexes in nuclear medicine (ie for the labeling of receptor binding biomolecules like steroid hormones, brain tracers, and others) has been proposed in the literature. 1-4 Those approaches, however, were based on classical organometallic syntheses, and thus, the routine use suffered from the lack of practical preparations of precursors. The radionuclide 99mTc is important in diagnostic nuclear medicine. It is inexpensive and readily available in any hospital. Consequently, it is of high priority to develop efficient labeling methods (in terms of yield and ligand/metal ratio) for biomolecules, derivatized with a chelating function for the 99mTc center. To date, the published methods mostly rely on the stabilization of Tc (V) with tetradentate N and S ligands. 5-8 Besides nonpredictable retention of biological activity of such conjugates, the methods entailed in most cases purification either from cold, unlabeled material (receptor saturation) or from decomposition products such as 99mTcO2.